BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 25453534)

  • 1. Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial.
    Tang WHW; Dupont M; Hernandez AF; Voors AA; Hsu AP; Felker GM; Butler J; Metra M; Anker SD; Troughton RW; Gottlieb SS; McMurray JJ; Armstrong PW; Massie BM; Califf RM; O'Connor CM; Starling RC
    JACC Heart Fail; 2015 Jan; 3(1):40-49. PubMed ID: 25453534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Grodin JL; Perez AL; Wu Y; Hernandez AF; Butler J; Metra M; Felker GM; Voors AA; McMurray JJ; Armstrong PW; Califf RM; Starling RC; O'Connor CM; Tang WH
    JACC Heart Fail; 2015 Oct; 3(10):777-85. PubMed ID: 26449997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA
    Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
    Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
    JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.
    Ezekowitz JA; Hernandez AF; O'Connor CM; Starling RC; Proulx G; Weiss MH; Bakal JA; Califf RM; McMurray JJ; Armstrong PW
    J Am Coll Cardiol; 2012 Apr; 59(16):1441-8. PubMed ID: 22497823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.
    Dupont M; Wu Y; Hazen SL; Tang WH
    Circ Heart Fail; 2012 Sep; 5(5):602-9. PubMed ID: 22899766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.
    Chen HH; Anstrom KJ; Givertz MM; Stevenson LW; Semigran MJ; Goldsmith SR; Bart BA; Bull DA; Stehlik J; LeWinter MM; Konstam MA; Huggins GS; Rouleau JL; O'Meara E; Tang WH; Starling RC; Butler J; Deswal A; Felker GM; O'Connor CM; Bonita RE; Margulies KB; Cappola TP; Ofili EO; Mann DL; Dávila-Román VG; McNulty SE; Borlaug BA; Velazquez EJ; Lee KL; Shah MR; Hernandez AF; Braunwald E; Redfield MM;
    JAMA; 2013 Dec; 310(23):2533-43. PubMed ID: 24247300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory study.
    Chow SL; O'Barr SA; Peng J; Chew E; Pak F; Quist R; Patel P; Patterson JH; Heywood JT
    Circ Heart Fail; 2011 Jul; 4(4):450-5. PubMed ID: 21576282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure.
    Manzano-Fernández S; Januzzi JL; Boronat-Garcia M; Bonaque-González JC; Truong QA; Pastor-Pérez FJ; Muñoz-Esparza C; Pastor P; Albaladejo-Otón MD; Casas T; Valdés M; Pascual-Figal DA
    J Am Coll Cardiol; 2011 Feb; 57(7):849-58. PubMed ID: 21310322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study.
    Chatterjee NA; Singh JP; Szymonifka J; Deaño RC; Thai WE; Wai B; Min JK; Januzzi JL; Truong QA
    Int J Cardiol; 2016 Feb; 205():43-49. PubMed ID: 26710332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
    Arora S; Clarke K; Srinivasan V; Gradman A
    QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
    Dandamudi S; Chen HH
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of concordance in defining worsening renal function by rise in creatinine vs rise in cystatin C.
    Dupont M; Shrestha K; Singh D; Finucan M; Tang WH
    Congest Heart Fail; 2013; 19(4):E17-21. PubMed ID: 23294667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nesiritide in patients with acute decompensated heart failure.
    O'Connor CM; Starling RC; Hernandez AF; Armstrong PW; Dickstein K; Hasselblad V; Heizer GM; Komajda M; Massie BM; McMurray JJ; Nieminen MS; Reist CJ; Rouleau JL; Swedberg K; Adams KF; Anker SD; Atar D; Battler A; Botero R; Bohidar NR; Butler J; Clausell N; Corbalán R; Costanzo MR; Dahlstrom U; Deckelbaum LI; Diaz R; Dunlap ME; Ezekowitz JA; Feldman D; Felker GM; Fonarow GC; Gennevois D; Gottlieb SS; Hill JA; Hollander JE; Howlett JG; Hudson MP; Kociol RD; Krum H; Laucevicius A; Levy WC; Méndez GF; Metra M; Mittal S; Oh BH; Pereira NL; Ponikowski P; Tang WH; Tanomsup S; Teerlink JR; Triposkiadis F; Troughton RW; Voors AA; Whellan DJ; Zannad F; Califf RM
    N Engl J Med; 2011 Jul; 365(1):32-43. PubMed ID: 21732835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide.
    Miller WL; Kurien S; Warfield KT; Wood CM; Jaffe AS
    Int J Cardiol; 2008 May; 126(2):234-9. PubMed ID: 17482692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.